Venture Funding Keeps A Steady Pace In Q1

Posted on by admin

[ad_1]

At $7.94bn, the first quarter of 2026 fell only slightly below the $8.04bn in venture capital raised by biopharma companies in Q4 of 2025, which was the biggest quarter in years.

[ad_2]

Related Posts